Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Division of Oncology UNC Chapel HL
3009 Old Clinic Bldg Cb7305
Chapel Hill, NC 27599Phone+1 919-843-6281Fax+1 984-974-8615
Education & Training
University of North Carolina HospitalsResidency, Public Health and General Preventive Medicine, 2006 - 2008- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2005 - 2007
- University of North Carolina HospitalsResidency, Internal Medicine, 2002 - 2005
Northeast Ohio Medical UniversityClass of 2002
Certifications & Licensure
NC State Medical License 2002 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer Start of enrollment: 2011 Nov 01
- LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations Start of enrollment: 2013 Apr 04
Publications & Presentations
PubMed
- North American Cancer Center Clinical Research Capacity and Benchmarking in the Postpandemic Era.Margaret Kasner, Angela H Fritsche, Man Chong Leong, Kendra Cameron, Carrie B Lee
JCO Oncology Practice. 2024-12-01 - FDG PET in a Patient on a GLP-1 Agonist/Insulin Secretagogue.Jorge D Oldan, Paula G Landman, Jennifer A Schroeder, Amir H Khandani, Lilja B Solnes
Clinical Nuclear Medicine. 2024-09-01 - 112 citationsDurvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(...Jonathan D Schoenfeld, Anita Giobbie-Hurder, Srinika Ranasinghe, Katrina Z Kao, Ana Lako
The Lancet. Oncology. 2022-02-01
Press Mentions
The Topic of CancerJune 17th, 2022
Melanoma Survivors Share Stories of Recovery Amid Treatment AdvancesMay 29th, 2018- UNC Lineberger Named as a National Research Hub for NIH Cancer Screening StudyFebruary 22nd, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
